Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.140
0.00 (0.00%)
May 20, 2026, 4:00 PM EDT - Market closed

Estrella Immunopharma Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Estrella Immunopharma in the last 12 months.

Price Target: $12 (+952.63%)
Analyst Consensus: n/a
TargetLowAverageMedianHigh
Price$12$12$12$12
Change+952.63%+952.63%+952.63%+952.63%
* Price targets were last updated on Feb 9, 2026.

Analyst Ratings

There are currently no analyst ratings available for Estrella Immunopharma.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy111111
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$8
Strong BuyMaintains$8+601.75%Feb 9, 2026
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$16$8
Strong BuyMaintains$16$8+601.75%Jan 28, 2026
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$16
Strong BuyMaintains$16+1,303.51%Nov 3, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$16
Strong BuyMaintains$16+1,303.51%Aug 12, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$16
Strong BuyMaintains$16+1,303.51%Jun 3, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-39.78
from -0.35
EPS Next Year
-32.64
from -39.78
Fiscal YearFY 2022FY 2023FY 2024FY 2024FY 2025FY 2026FY 2027
Period EndingJun 30, 2022Jun 30, 2023Jun 30, 2024Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
-------
Revenue Growth
-------
EPS
--36.35-0.27-0.24-0.35-39.78-32.64
EPS Growth
-------
Forward PE
-------
No. Analysts
-----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030203120322033
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030203120322033
High--
Avg--
Low--

EPS Forecast

EPS20262027202820292030203120322033
High-40.95-33.60
Avg-39.78-32.64
Low-38.22-31.36

EPS Growth

EPS Growth20262027202820292030203120322033
High--
Avg--
Low--
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.